Antimicrobial Peptide Mimics for Clinical Use: Does Size Matter?

amphiphilic antibiotic antimicrobial peptides clinical development peptidomimetics resistant bacteria synthetic mimic

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 07 04 2022
accepted: 29 04 2022
entrez: 20 6 2022
pubmed: 21 6 2022
medline: 22 6 2022
Statut: epublish

Résumé

The search for efficient antimicrobial therapies that can alleviate suffering caused by infections from resistant bacteria is more urgent than ever before. Infections caused by multi-resistant pathogens represent a significant and increasing burden to healthcare and society and researcher are investigating new classes of bioactive compounds to slow down this development. Antimicrobial peptides from the innate immune system represent one promising class that offers a potential solution to the antibiotic resistance problem due to their mode of action on the microbial membranes. However, challenges associated with pharmacokinetics, bioavailability and off-target toxicity are slowing down the advancement and use of innate defensive peptides. Improving the therapeutic properties of these peptides is a strategy for reducing the clinical limitations and synthetic mimics of antimicrobial peptides are emerging as a promising class of molecules for a variety of antimicrobial applications. These compounds can be made significantly shorter while maintaining, or even improving antimicrobial properties, and several downsized synthetic mimics are now in clinical development for a range of infectious diseases. A variety of strategies can be employed to prepare these small compounds and this review describes the different compounds developed to date by adhering to a minimum pharmacophore based on an amphiphilic balance between cationic charge and hydrophobicity. These compounds can be made as small as dipeptides, circumventing the need for large compounds with elaborate three-dimensional structures to generate simplified and potent antimicrobial mimics for a range of medical applications. This review highlight key and recent development in the field of small antimicrobial peptide mimics as a promising class of antimicrobials, illustrating just how small you can go.

Identifiants

pubmed: 35720375
doi: 10.3389/fimmu.2022.915368
pmc: PMC9204644
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0
Antimicrobial Cationic Peptides 0
Antimicrobial Peptides 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

915368

Informations de copyright

Copyright © 2022 Svenson, Molchanova and Schroeder.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Chem Rev. 2005 Mar;105(3):793-826
pubmed: 15755077
J Med Chem. 2011 Aug 25;54(16):5786-95
pubmed: 21732630
ACS Infect Dis. 2022 Mar 11;8(3):533-545
pubmed: 35175731
Expert Opin Biol Ther. 2011 Nov;11(11):1469-84
pubmed: 21939428
J Pept Sci. 2005 Jul;11(7):379-89
pubmed: 15635665
Eur J Med Chem. 2020 Sep 15;202:112596
pubmed: 32659547
J Pept Sci. 2001 Apr;7(4):190-6
pubmed: 11354462
Curr Pharm Des. 2010;16(28):3071-88
pubmed: 20687879
Expert Opin Ther Pat. 2016 Jun;26(6):689-702
pubmed: 27063450
Biochemistry. 2008 Oct 7;47(40):10630-6
pubmed: 18783248
Sci Total Environ. 2022 Mar 15;812:152487
pubmed: 34953845
Eur J Med Chem. 2021 Dec 15;226:113813
pubmed: 34520955
ACS Macro Lett. 2020 Apr 21;9(4):494-499
pubmed: 32337093
AAPS J. 2015 Jan;17(1):134-43
pubmed: 25366889
PLoS One. 2016 Jun 09;11(6):e0157306
pubmed: 27280777
Front Microbiol. 2021 Dec 23;12:803309
pubmed: 35003035
Lancet. 2010 May 1;375(9725):1569-77
pubmed: 20413151
J Nat Prod. 2009 Jun;72(6):1115-20
pubmed: 19505081
Drug Discov Today. 2010 Jan;15(1-2):40-56
pubmed: 19879957
Chem Rev. 2002 Dec;102(12):4501-24
pubmed: 12475199
Trends Biotechnol. 2011 Sep;29(9):464-72
pubmed: 21680034
Nat Rev Drug Discov. 2021 Apr;20(4):309-325
pubmed: 33536635
J Med Chem. 2011 Apr 14;54(7):2422-32
pubmed: 21401113
Int J Antimicrob Agents. 2020 Aug;56(2):106048
pubmed: 32540430
J Biol Chem. 2004 Aug 13;279(33):34705-14
pubmed: 15166237
Eur J Med Chem. 2021 Feb 15;212:113138
pubmed: 33422980
J Biol Chem. 2003 Feb 7;278(6):4057-62
pubmed: 12441339
J Med Chem. 2016 Sep 8;59(17):7877-87
pubmed: 27526720
Chemistry. 2009 Nov 9;15(44):11784-800
pubmed: 19798714
Acc Chem Res. 2008 Oct;41(10):1233-40
pubmed: 18616297
J Antimicrob Chemother. 2009 Oct;64(4):735-40
pubmed: 19689976
Chem Commun (Camb). 2011 Sep 14;47(34):9729-31
pubmed: 21779608
ACS Infect Dis. 2021 Oct 8;7(10):2864-2875
pubmed: 34505771
J Med Chem. 2012 Jul 26;55(14):6294-305
pubmed: 22720778
Int J Antimicrob Agents. 2015 Nov;46(5):568-71
pubmed: 26395218
J Med Chem. 2003 Apr 24;46(9):1567-70
pubmed: 12699374
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2794-9
pubmed: 18287037
Acc Chem Res. 2019 Mar 19;52(3):749-759
pubmed: 30829472
J Med Chem. 2017 Feb 23;60(4):1362-1378
pubmed: 28122182
Int J Mol Sci. 2022 Apr 21;23(9):
pubmed: 35563014
Clin Microbiol Rev. 2006 Jul;19(3):491-511
pubmed: 16847082
J Pept Sci. 2002 Aug;8(8):431-7
pubmed: 12212806
J Med Chem. 2017 Apr 13;60(7):2745-2763
pubmed: 28290692
Cell Rep. 2021 Nov 2;37(5):109931
pubmed: 34731621
Trends Biotechnol. 1992 Jun;10(6):208-17
pubmed: 1368395
Sci Total Environ. 2018 Dec 1;643:98-106
pubmed: 29936172
J Pept Sci. 2001 Aug;7(8):425-32
pubmed: 11548058
Biomolecules. 2018 Apr 19;8(2):
pubmed: 29671805
Crit Rev Biotechnol. 2020 Nov;40(7):978-992
pubmed: 32781848
J Med Chem. 2012 Feb 9;55(3):1296-302
pubmed: 22243686
Biomolecules. 2021 Aug 13;11(8):
pubmed: 34439870
Appl Microbiol Biotechnol. 2013 Apr;97(7):3085-96
pubmed: 23053090
J Antibiot (Tokyo). 2021 May;74(5):337-345
pubmed: 33495549
Acta Pharm Sin B. 2021 Sep;11(9):2609-2644
pubmed: 34589385
Biochemistry. 1971 Oct 26;10(22):4033-9
pubmed: 4334402
J Antimicrob Chemother. 2008 Feb;61(2):365-70
pubmed: 18079128
Cell Host Microbe. 2012 Dec 13;12(6):815-23
pubmed: 23245326
J Hazard Mater. 2021 Apr 5;407:124827
pubmed: 33352424
Chem Rev. 2012 Jul 11;112(7):3641-716
pubmed: 22575049
Chem Soc Rev. 2021 Jul 5;50(13):7820-7880
pubmed: 34042120
Chem Commun (Camb). 2019 Apr 9;55(30):4307-4310
pubmed: 30789174
Eur J Med Chem. 2018 Dec 5;160:9-22
pubmed: 30316060
Molecules. 2020 Jan 08;25(2):
pubmed: 31936341
Bioorg Med Chem. 2018 Jun 1;26(10):2700-2707
pubmed: 28720325
Antimicrob Agents Chemother. 2011 Jun;55(6):3058-62
pubmed: 21464254
ACS Med Chem Lett. 2022 Apr 05;13(4):632-640
pubmed: 35450374
J Org Chem. 2007 Jan 5;72(1):195-9
pubmed: 17194099
Crit Rev Biotechnol. 2017 May;37(3):393-410
pubmed: 27098391
Chembiochem. 2014 Oct 13;15(15):2275-80
pubmed: 25169879
Cell Mol Life Sci. 2011 Jul;68(13):2267-80
pubmed: 21573781
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Jan-Feb;5(1):49-66
pubmed: 23076870
J Med Chem. 2015 Jan 22;58(2):739-52
pubmed: 25474410
Acc Chem Res. 2013 Dec 17;46(12):2977-87
pubmed: 24007507
Bioconjug Chem. 2021 Mar 17;32(3):395-410
pubmed: 33683873
Antimicrob Agents Chemother. 2014 Sep;58(9):5136-45
pubmed: 24936592
Sci Rep. 2020 Aug 6;10(1):13206
pubmed: 32764602
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Commun Biol. 2021 May 21;4(1):605
pubmed: 34021253
J Med Chem. 2017 Oct 26;60(20):8456-8465
pubmed: 28984451
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15997-6002
pubmed: 17038500
J Med Chem. 2017 Jul 27;60(14):6152-6165
pubmed: 28636355
J Med Chem. 2018 Apr 12;61(7):2865-2874
pubmed: 29569910
Molecules. 2018 Feb 04;23(2):
pubmed: 29401708
FEBS Lett. 2001 Jul 20;501(2-3):146-50
pubmed: 11470274
Adv Drug Deliv Rev. 2021 Mar;170:261-280
pubmed: 33400958
Org Biomol Chem. 2015 Jun 14;13(22):6225-41
pubmed: 25958967
Curr Protein Pept Sci. 2006 Dec;7(6):479-86
pubmed: 17168781
Pharmacotherapy. 2004 Jan;24(1):41-57
pubmed: 14740787
Eur J Med Chem. 2020 Mar 1;189:112072
pubmed: 31991335
Biochimie. 2010 Sep;92(9):1236-41
pubmed: 20188791
Chem Biol. 2006 Apr;13(4):427-35
pubmed: 16632255
Front Chem. 2021 Jun 18;9:691532
pubmed: 34222199
Chem Commun (Camb). 2011 Nov 28;47(44):12197-12199
pubmed: 21963627
Biochemistry. 2008 Mar 25;47(12):3777-88
pubmed: 18307313
ACS Med Chem Lett. 2013 May 9;4(5):481-485
pubmed: 23814644
Curr Med Chem. 2007;14(1):1-18
pubmed: 17266565
Acc Chem Res. 2021 Jan 5;54(1):104-119
pubmed: 33346639
Sci Rep. 2020 Sep 9;10(1):14805
pubmed: 32908179
ACS Infect Dis. 2020 Jun 12;6(6):1413-1426
pubmed: 32357292
J Med Chem. 2019 Nov 27;62(22):10294-10304
pubmed: 31664827
Clin Infect Dis. 2003 Jun 1;36(11):1445-57
pubmed: 12766841
Acta Paediatr Jpn. 1994 Oct;36(5):585-91
pubmed: 7825467
Org Biomol Chem. 2018 Aug 15;16(32):5871-5888
pubmed: 30070287
Front Chem. 2020 May 21;8:416
pubmed: 32528930
Chem Commun (Camb). 2010 May 14;46(18):3197-9
pubmed: 20424772
Front Microbiol. 2019 Feb 20;10:275
pubmed: 30842761
J Med Chem. 2008 Jul 24;51(14):4306-14
pubmed: 18570363
J Med Chem. 2010 Jan 28;53(2):595-606
pubmed: 19994905
ACS Chem Biol. 2021 Dec 17;16(12):2731-2745
pubmed: 34779605
Drug Discov Today. 2014 Nov;19(11):1731-1743
pubmed: 24997281
Langmuir. 2020 Nov 3;36(43):12900-12910
pubmed: 33085895
Eur J Pharm Sci. 2006 Jan;27(1):80-90
pubmed: 16246536
Biofouling. 2015;31(4):393-403
pubmed: 26057499
Nat Commun. 2022 Mar 25;13(1):1625
pubmed: 35338128
Chemistry. 2018 Jun 7;24(32):8217-8227
pubmed: 29600579
J Nat Prod. 2011 Apr 25;74(4):837-41
pubmed: 21370896
ACS Infect Dis. 2019 Sep 13;5(9):1535-1545
pubmed: 31328496
Cell Mol Life Sci. 2007 Apr;64(7-8):922-33
pubmed: 17310278
Front Neurol. 2020 Feb 25;11:108
pubmed: 32158425
Front Microbiol. 2020 Mar 17;11:417
pubmed: 32256474
Eur J Med Chem. 2018 Jan 1;143:1702-1722
pubmed: 29133052
Sci Rep. 2017 Jul 4;7(1):4610
pubmed: 28676673
J Med Chem. 2004 Aug 12;47(17):4159-62
pubmed: 15293987
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Viruses. 2021 Feb 09;13(2):
pubmed: 33572467
J Org Chem. 2019 Apr 19;84(8):4615-4628
pubmed: 30900880
Nat Prod Rep. 2005 Dec;22(6):717-41
pubmed: 16311632
Mol Pharm. 2016 Oct 3;13(10):3595-3600
pubmed: 27576445
J Antimicrob Chemother. 2011 Apr;66(4):859-62
pubmed: 21393138
Org Biomol Chem. 2008 Feb 7;6(3):417-23
pubmed: 18219405
ACS Med Chem Lett. 2012 Jul 12;3(8):683-6
pubmed: 24900530
Antimicrob Agents Chemother. 2010 Oct;54(10):4049-58
pubmed: 20696877
Biochemistry. 1998 Mar 24;37(12):4288-98
pubmed: 9521752
Antibiotics (Basel). 2020 Jan 13;9(1):
pubmed: 31941022
Front Cell Infect Microbiol. 2016 Dec 27;6:194
pubmed: 28083516
Clin Immunol. 2010 Apr;135(1):1-11
pubmed: 20116332
J Med Chem. 2007 Jul 12;50(14):3334-9
pubmed: 17569519
Lancet Infect Dis. 2020 Sep;20(9):e216-e230
pubmed: 32653070
J Glob Antimicrob Resist. 2022 Jun;29:185-193
pubmed: 34954415
J Pept Res. 2000 Nov;56(5):265-74
pubmed: 11095180
Pharmacol Rev. 2003 Mar;55(1):27-55
pubmed: 12615953
J Med Chem. 2011 Feb 10;54(3):858-68
pubmed: 21218818
Biochem Cell Biol. 2002;80(1):65-74
pubmed: 11908644
Antimicrob Agents Chemother. 2013 Aug;57(8):4050-2
pubmed: 23716061
Antimicrob Agents Chemother. 2011 Nov;55(11):5043-53
pubmed: 21844313
Antimicrob Agents Chemother. 2014 Jul;58(7):3820-7
pubmed: 24752272
FEBS Lett. 2003 Mar 13;538(1-3):65-70
pubmed: 12633854
Front Chem. 2020 Jun 12;8:441
pubmed: 32596202
J Mol Recognit. 2013 Oct;26(10):461-9
pubmed: 23996488
ACS Appl Mater Interfaces. 2020 May 13;12(19):21292-21299
pubmed: 31944092
Biopolymers. 2015 May;104(3):129-47
pubmed: 25808118
Nature. 2002 Jan 24;415(6870):389-95
pubmed: 11807545
J Med Virol. 2022 May;94(5):2188-2200
pubmed: 35080027
J Mol Biol. 1997 Nov 28;274(2):222-36
pubmed: 9398529
ChemMedChem. 2017 Feb 20;12(4):312-318
pubmed: 28052595
BMC Struct Biol. 2014 Jan 23;14:4
pubmed: 24456893
Biomolecules. 2018 Jan 19;8(1):
pubmed: 29351202
J Appl Microbiol. 2011 Jan;110(1):229-38
pubmed: 20961363
Chem Commun (Camb). 2021 Nov 4;57(88):11578-11590
pubmed: 34652348
J Antimicrob Chemother. 2018 Jan 01;73(1):143-150
pubmed: 29029265
Curr Top Med Chem. 2017;17(5):576-589
pubmed: 27411325
Biochim Biophys Acta. 2006 Sep;1758(9):1387-92
pubmed: 16626628
J Med Chem. 2021 Aug 12;64(15):11395-11417
pubmed: 34314189
J Pharmacol Exp Ther. 2010 Mar;332(3):1032-9
pubmed: 19952307
J Med Chem. 2010 Aug 12;53(15):5558-66
pubmed: 20608742
Front Microbiol. 2020 Oct 16;11:582779
pubmed: 33178164
Chem Commun (Camb). 2020 Sep 24;56(76):11158-11168
pubmed: 32870199
Eur J Med Chem. 2019 Dec 1;183:111671
pubmed: 31536892
J Pept Sci. 2018 Jul;24(7):e3090
pubmed: 29845683
Curr Opin Biotechnol. 2008 Dec;19(6):620-7
pubmed: 18996193
Mol Pharm. 2009 May-Jun;6(3):996-1005
pubmed: 19341291
Nat Rev Drug Discov. 2003 Nov;2(11):891-902
pubmed: 14668810
Antimicrob Agents Chemother. 2007 Jan;51(1):354-8
pubmed: 17060532
Chem Commun (Camb). 2017 Oct 31;53(87):11948-11951
pubmed: 29052670
Antibiotics (Basel). 2022 Mar 03;11(3):
pubmed: 35326798

Auteurs

Johan Svenson (J)

Cawthron Institute, Nelson, New Zealand.

Natalia Molchanova (N)

The Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA, United States.

Christina I Schroeder (CI)

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, United States.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Populus Soil Microbiology Soil Microbiota Fungi
Aerosols Humans Decontamination Air Microbiology Masks

Classifications MeSH